UREMOL HC 10 % — DIN 00503134
UREA : 10 % HYDROCORTISONE ACETATE : 1 % · GLAXOSMITHKLINE INC · CREAM · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is UREMOL HC?
UREMOL HC 10 % contains UREA : 10 % HYDROCORTISONE ACETATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 00503134, held by GLAXOSMITHKLINE INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Jun-2014. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is UREMOL HC used for?
Topical therapy of corticosteroid responsive dermatoses with dry skin conditions where anti-inflammatory and antipruritic activity is required. Maximum duration 4 weeks.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Hydrocortisone cost around the world?
Hydrocortisone is listed on 15 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 11 | 71 | USD███.██ |
| South Africa | single exit price | 15 | 22 | ZAR███.██ |
| Saudi Arabia | public | 16 | 16 | SAR███.██ |
| Greece | producer price (ex-factory) | 15 | 15 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 9 | 9 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 5 | 9 | CZK███.██ |
| Australia | ex-manufacturer | 4 | 8 | AUD███.██ |
| United Arab Emirates | public | 4 | 6 | AED███.██ |
| Bahrain | retail (max) | 4 | 6 | BHD███.██ |
| Morocco | PPV (public price) | 5 | 6 | MAD███.██ |
| United Kingdom | hospital | 5 | 5 | GBP███.██ |
| Luxembourg | reimbursement | 4 | 4 | EUR███.██ |
| Iceland | max wholesale | 3 | 3 | ISK███.██ |
| Norway | max AUP (pharmacy retail) | 2 | 2 | NOK███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
183 pack listings across 103 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Hydrocortisone pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Hydrocortisone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
5 holders have a Canadian DIN containing Hydrocortisone, across 8 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| DERMTEK PHARMA INC | 2 | 2 | PRAMOX HC CREAM, PRAMOX HC LOTION | Sourceable in Canada |
| GLAXOSMITHKLINE INC | 2 | 0 | UREMOL HC | No marketed DIN |
| INTERNATIONAL DERMATOLOGICALS INC. | 2 | 0 | STEREX CRM PLUS, STEREX LOT PLUS | No marketed DIN |
| GALDERMA CANADA INC | 1 | 0 | CALMURID HC CRM | No marketed DIN |
| MERIT INDUSTRIES INC. | 1 | 0 | TI-U-LAC HC LOTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 10 % |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
| Pack configuration (monograph) | Not explicitly detailed in text (mentions 'container' and 'excess product should not be returned to the container'). |
| Storage | Not specified in provided text (Table of Contents lists section but text ends before it). |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Hydrocortisone |
|---|---|
| ATC code | D07XA01 |
| AHFS class | 84:06.00 ; 84:28.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00503134 |
|---|---|
| DIN (unpadded, as printed on some documents) | 503134 |
| Brand name | UREMOL HC |
| Generic / active ingredient | UREA : 10 % HYDROCORTISONE ACETATE : 1 % |
| Market authorization holder | GLAXOSMITHKLINE INC |
| Health Canada schedule | Prescription |
| ATC code | D07XA01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D07XA |
| Current status | CANCELLED POST MARKET |
| Status date | 23-Jun-2014 |
| Original market date | 1981-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Apply a thin layer to affected areas once or twice a day for a maximum of 4 weeks. Affected area should be clean and dry. Avoid abrupt discontinuation.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to hydrocortisone, urea, or other corticosteroids; bacterial, tubercular, fungal, viral, or parasitic skin infections; rosacea; acne vulgaris; pruritus without inflammation; eye use.
Warnings and precautions
Risk of HPA axis suppression and Cushing’s syndrome; do not use under occlusion; keep away from eyes/mucous membranes; avoid use on open wounds; potential for skin atrophy with prolonged use.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 8 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| PRAMOX HC CREAM | 1 % | CREAM | DERMTEK PHARMA INC | MARKETED | 00770957 |
| PRAMOX HC LOTION | 1 % | LOTION | DERMTEK PHARMA INC | MARKETED | 01954210 |
| CALMURID HC CRM | 100 MG | CREAM | GALDERMA CANADA INC | CANCELLED POST MARKET | 02010720 |
| STEREX CRM PLUS | 1 % | CREAM | INTERNATIONAL DERMATOLOGICALS INC. | CANCELLED POST MARKET | 00449768 |
| STEREX LOT PLUS | 3 % | LOTION | INTERNATIONAL DERMATOLOGICALS INC. | CANCELLED POST MARKET | 00456403 |
| TI-U-LAC HC LOTION | 100 MG | LOTION | MERIT INDUSTRIES INC. | CANCELLED POST MARKET | 01944096 |
| UREMOL HC | 1 % | LOTION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | 00560022 |
2 · Same class — other molecules in ATC D07XA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Hydrocortisone | CALMURID HC CRM · PRAMOX HC CREAM · PRAMOX HC LOTION · STEREX CRM PLUS · +3 more | 8 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D07X
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D07XC | Betamethasone · Diflucortolone | 5 | 2 |
| D07XB | Flumetasone | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is UREMOL HC called?
The same molecule, Hydrocortisone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Alfacort | Latin | Bahrain, Saudi Arabia, United Arab Emirates |
| HYDROCORTISON VUAB | Latin | Czechia |
| Dilucort | Latin | South Africa |
| HYDROCORTISONE LEURQUIN | Latin | Morocco |
| Macleods Hydrocortisone Injection | Latin | South Africa |
| Softacort | Latin | Czechia, Iceland |
| Terracortril | Latin | South Africa |
| Acecort | Latin | Norway |
| CANDICORT CREAM | Latin | Saudi Arabia |
| COLIRCUSI H.C WITH NEOM | Latin | Saudi Arabia |
| CORTIDERM | Latin | Bahrain |
| Cortotic Vet | Latin | Iceland |
| Covocort | Latin | South Africa |
| Daktacort | Latin | South Africa |
| EFFICORT HYDROPHILE | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.